MwanzoHPX • FRA
add
Hisamitsu Pharmaceutical Co Inc
Bei iliyotangulia
€ 25.60
Bei za siku
€ 25.80 - € 25.80
Bei za mwaka
€ 21.00 - € 28.80
Thamani ya kampuni katika soko
364.25B JPY
Wastani wa hisa zilizouzwa
6.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
TYO
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(JPY) | Ago 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 39.65B | 13.66% |
Matumizi ya uendeshaji wa biashara | 18.75B | 17.95% |
Mapato halisi | 4.31B | -1.33% |
Kiwango cha faida halisi | 10.87 | -13.18% |
Mapato kwa kila hisa | — | — |
EBITDA | 6.35B | 20.49% |
Asilimia ya kodi ya mapato | 28.38% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(JPY) | Ago 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 122.74B | -13.22% |
Jumla ya mali | 350.48B | 1.79% |
Jumla ya dhima | 74.55B | 7.74% |
Jumla ya hisa | 275.92B | — |
hisa zilizosalia | 73.34M | — |
Uwiano wa bei na thamani | 0.01 | — |
Faida inayotokana na mali | 3.52% | — |
Faida inayotokana mtaji | 4.46% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(JPY) | Ago 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 4.31B | -1.33% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
The Hisamitsu Pharmaceutical Co., Inc., headquartered in Saga and Tokyo, is a Japanese multinational pharmaceutical corporation that develops and markets prescription and over-the-counter drug products, especially external pain relieving products such as the transdermal patch. Hisamitsu has specialised in transdermal drug delivery system technology since the introduction of its original line of patches in 1903.
Hisamitsu's products under the Salonpas and Bye-Bye Fever brands are exported to over fifty countries. Hisamitsu also manufactures the Mohrus and Mohrus-Tape lines of external pain relief prescription products for the Japanese drug market. The company also manufactures internal medicines, eyedrops for general application, and the Lifecella Face Mask, a skincare product. Hisamitsu has developed the only over-the-counter transdermal patches approved by the U.S Food and Drug Administration. Wikipedia
Ilianzishwa
1847
Makao Makuu
Tovuti
Wafanyakazi
2,759